Neuracle Science Co., Ltd. · Biologic · Phase 1/2
ActiveTherapeuticStronger sources
Evidence
trial
Confidence
92%
Indications
Hearing LossSensorineural Hearing LossSudden Sensorineural Hearing LossCochlear Synaptopathy
Population
AdultSudden / SSNHLSensorineuralSalvage Therapy
